10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2015

OR

[ ] TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

COMMISSION FILE NO. 0-17629

ADM TRONICS UNLIMITED, INC.
(Exact name of registrant as specified in its charter)

 Delaware (State or Other Jurisdiction of Incorporation or organization) 22-1896032 (I.R.S. Employer Identification Number)

224-S Pegasus Ave., Northvale, New Jersey 07647
(Address of Principal Executive Offices)

Registrant's Telephone Number, including area code: (201) 767-6040

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  YES [X] NO [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [  ]	Accelerated filer  [  ]
Non-accelerated filer [  ] (Do not check if a smaller reporting company)	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [  ] NO [X]

State the number of shares outstanding of each of the Issuer's classes of common equity, as of the latest practicable date:

67,008,502 shares of Common Stock, $.0005 par value, as of August 14, 2015.

ADM TRONICS UNLIMITED, INC., AND SUBSIDIARY 

INDEX

		Page
		Number
Part I - Financial Information
Item 1.	Condensed Consolidated Financial Statements:
	Condensed Consolidated Balance Sheets – June 30, 2015 (unaudited) and March 31, 2015		3
	Condensed Consolidated Statements of Operations for the three months ended June 30, 2015 and 2014 (unaudited)		4
	Condensed Consolidated Statements of Cash Flow for the three months ended June 30, 2015 and 2014 (unaudited)		5
	Notes to the Condensed Consolidated Financial Statements (unaudited)		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		10
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		14
Item 4.	Controls and Procedures		14
Part II - Other Information
Item 1.	Legal Proceedings		15
Item 1A.	Risk Factors		15
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		15
Item 3.	Defaults Upon Senior Securities		15
Item 4.	Mine Safety Disclosures		15
Item 5.	Other Information		15
Item 6.	Exhibits		15

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30,			March 31,
	2015			2015
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	370,526		$	216,395
Accounts receivable, net of allowance for doubtful accounts of $25,000 for each period		750,803			616,070
Inventories		166,792			137,704
Prepaid expenses and other current assets		29,414			16,595
Restricted cash		232,786			232,525
Total current assets		1,550,321			1,219,289
Property and equipment, net of accumulated depreciation of $74,522 and $74,070, respectively		2,794			3,246
Inventories - long-term portion		84,904			88,257
Intangible assets, net of accumulated amortization of $154,015 and $153,667, respectively		14,133			14,481
Other assets		16,144			16,144
Total other assets		117,975			122,128
Total assets	$	1,668,296		$	1,341,417
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Note payable - bank	$	114,966		$	121,966
Accounts payable		173,216			329,291
Accrued expenses and other current liabilities		266,840			221,106
Customer deposits		99,102			99,102
Due to shareholder		233,841			223,849
Total current liabilities		887,965			995,314
Total liabilities		887,965			995,314
Stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding		-			-
Common stock, $0.0005 par value; 150,000,000 authorized, 64,939,537 shares issued and outstanding at March 31, 2015 and 2014, respectively		32,470			32,470
Additional paid-in capital		32,298,094			32,298,094
Accumulated deficit		(31,550,233	)		(31,984,461	)
Total stockholders' equity		780,331			346,103
Total liabilities and stockholders' equity	$	1,668,296		$	1,341,417

The accompanying notes are an integral part of these 

condensed consolidated financial statements.

3

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED JUNE 30, 2015 AND 2014

(Unaudited)

	2015			2014
Net revenues	$	1,055,928		$	623,674
Cost of sales		300,873			338,216
Gross Profit		755,055			285,458
Operating expenses:
Research and development		24,689			12,045
Selling, general, and administrative		295,221			236,037
Depreciation and amortization		597			1,642
Total operating expenses		320,507			249,724
Income from operations		434,548			35,734
Other income (expense):
Interest income		321			1,047
Interest expense		(641	)		(953	)
Total other income (expense)		(320	)		94
Net income	$	434,228		$	35,828
Basic and diluted net income per common share:	$	0.01		$	0.00
Weighted average shares of common stock outstanding - basic		64,939,537			64,939,537
Weighted average shares of common stock outstanding - diluted		65,539,537			65,539,537

The accompanying notes are an integral part of these

condensed consolidated financial statements.

4

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED JUNE 30, 2015 AND 2014

(Unaudited)

	2015			2014
Cash flows from operating activities:
Net income	$	434,228		$	35,828
Adjustments to reconcile net income to net cash provided (used) in operating activities:
Depreciation and amortization		800			1,642
Interest receivable		-			(1,047	)
Increase (decrease) in cash flows as a result of changes in net assets and liabilities balances:
Accounts receivable		(134,733	)		(111,136	)
Inventory		(25,736	)		(82,996	)
Prepaid expenses and other current assets		(12,818	)		(23,838	)
Other assets		-			(1,000	)
Accounts payable		(156,075	)		47,442
Accrued expenses and other current liabilities		45,734			125,843
Due to shareholder		9,992			-
Total adjustments		(272,836	)		(45,090	)
Net cash provided (used) in operating activities		161,392			(9,262	)
Cash flows from investing activities:
Restricted cash		(261	)		-
Net cash used in investing activities		(261	)		-
Cash flows used in financing activities:
Repayments on note payable - Bank		(7,000	)		(4,000	)
Net cash used in financing activities		(7,000	)		(4,000	)
Net increase (decrease) in cash and cash equivalents		154,131			(13,262	)
Cash and cash equivalents - beginning of year		216,395			83,156
Cash and cash equivalents - end of year	$	370,526		$	69,894
Supplementary Disclosures of Cash Flow Information
Cash paid for:
Interest	$	641		$	953

The accompanying notes are an integral part of these

condensed consolidated financial statements.

5

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2015 AND 2014

NOTE 1 - NATURE OF BUSINESS

ADM Tronics Unlimited, Inc. ("we", "us", the “Company" or "ADM"), was incorporated under the laws of the state of Delaware on November 24, 1969. We are an engineering and manufacturing concern whose principal lines of business are engineering and manufacturing of electronics, primarily medical electronic devices, and the development, production and sale of chemical products.

The accompanying condensed consolidated financial statements as of June 30, 2015 (unaudited) and March 31, 2015 and for the three month periods ended June 30, 2015 and 2014 (unaudited) have been prepared by ADM pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the condensed financial position and operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the information included under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with the audited financial statements and explanatory notes for the year ended March 31, 2015 as disclosed in our annual report on Form 10-K for that year . The operating results and cash flows for three months ended June 30, 2015 (unaudited) are not necessarily indicative of the results to be expected for the pending full year ending March 31, 2016.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its subsidiary Sonotron. All significant intercompany balances and transactions have been eliminated in consolidation.

USE OF ESTIMATES

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our medical devices, reserves, deferred tax assets, valuation allowance, impairment of long lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others, option and warrant expenses related to compensation to employees and directors, consultants and investment banks, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates. 

REVENUE RECOGNITION

CHEMICAL PRODUCTS:

 Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

6

ELECTRONICS: 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. We have no other post shipment obligations. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for each of the fiscal years ended March 31, 2015 and 2014. For contract manufacturing, revenues are recognized after shipment of the completed products. 

ENGINEERING SERVICES: 

We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services as the services are provided.

 NET INCOME PER SHARE

Basic net income per share is calculated based on the weighted average number of common shares outstanding during the periods. Diluted net income per share is computed similar to basic income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive.

Per share basic and diluted net income amounted to $0.01 and $0.00 for the three months ended June 30, 2015 and 2014, respectively. There were 600,000 common stock equivalents at June 30, 2015 and 2014, respectively.

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current period presentation.

RECENT ACCOUNTING PRONOUNCEMENTS

Management does not believe that any recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

NOTE 3 - INVENTORIES

Inventories at June 30, 2015 consisted of the following:

	Current		Long Term		Total
Raw materials	$	139,584	$	84,285	$	223,869
Finished Goods		27,208		619		27,827
	$	166,792	$	84,904	$	251,696

Inventories at March 31, 2015 consisted of the following:

	Current		Long Term		Total
Raw materials	$	95,702	$	87,638	$	183,340
Finished Goods		42,002		619		42,621
	$	137,704	$	88,257	$	225,961

7

The Company values its inventories on the first in, first out ("FIFO") method at the lower of cost or market.

NOTE 4 – CONCENTRATIONS

During the three month period ended June 30, 2015, one customer accounted for 46% of our revenue and approximately 48% of our accounts receivable as of June 30, 2015.

During the three month period ended June 30, 2014, one customer accounted for 18% of our revenue. As of June 30, 2014, three customers represented approximately 52% of our accounts receivable.

The Company’s customer base is comprised of domestic and foreign entities with diverse demographics. Revenues from foreign customers represented $101,313 of net revenue or 9.6% for the three months ended June 30, 2015 and $40,095 of net revenue or 6.4% for the three months ended June 30, 2014.

As of June 30, 2015 and 2014, accounts receivable included $50,637 and $4,300, respectively, from foreign customers.

NOTE 5 - SEGMENT INFORMATION

Information about segments is as follows:

	Chemical		Electronics			Engineering			Total
Three months ended June 30, 2015
Revenue from external customers	$	365,944	$	175,229		$	514,755		$	1,055,928
Segment operating income (loss)	$	200,900	$	15,668		$	217,980		$	434,548
Year ended June 30, 2014
Revenue from external customers	$	297,159	$	242,210		$	84,305		$	623,674
Segment operating income (loss)	$	87,479	$	(8,836	)	$	(42,909	)	$	35,734
Total assets at June 30, 2015	$	578,168	$	276,851		$	813,277		$	1,668,296
Total assets at March 31, 2015	$	509,738	$	389,011		$	442,868		$	1,341,417

8

NOTE 6 - OPTIONS OUTSTANDING

During 2013, ADM granted an aggregate of 5,600,000 stock options to employees and consultants expiring at various dates through fiscal 2015. During 2014, 5,000,000 of the outstanding stock options were exercised. The options had various exercise prices and were fully vested at the date of grant. The options were valued at $55,997 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 4.9%, volatility of 414%, estimated useful life of 1.5 years and dividend rate of 0%. The following table summarizes information on all common share purchase options issued by us as of June 30, 2015 and 2014.

	2015				2014
	# of Shares		Weighted Average Exercise Price		# of Shares			Weighted Average Exercise Price
Outstanding, beginning of year		600,000	$	0.01		5,600,000		$	0.01
Issued		-	$	-		-		$	-
Exercised		-	$	-		(5,000,000	)	$	0.01
Expired		-	$	-		-		$	-
Outstanding, end of year		600,000	$	0.01		600,000		$	0.01
Exercisable, end of year		600,000	$	0.01		600,000		$	0.01

NOTE 7 - COMMITMENTS AND CONTINGENCIES

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on June 30, 2019. The Company’s future minimum lease commitment at June 30, 2015 is as follows:

For the twelve month period ending June 30,	Amount
2016	$	104,625
2017		104,625
2018		104,625
	$	313,875

Rent and real estate tax expense for all facilities for the three months ended June 30, 2015 and 2014 was approximately $31,000 respectively, for each period.

MASTER SERVICES AGREEMENT 

On February 12, 2010, ADM agreed to provide certain services to Ivivi Health Sciences, LLC (IHS) pursuant to a Master Services Agreement, as described below:

● We provided IHS with engineering services, including quality control and quality assurance services along with regulatory compliance services, warehouse fulfillment services and network administrative services including hardware and software services;

● Effective October 1, 2013 the monthly amount to be paid by IHS for these services was $3,000 plus additional amounts for individual projects requested from time to time by IHS. Pursuant to this agreement, revenues from engineering services to IHS were $9,000 for the three months ended June 30, 2015 and 2014 respectively.

9

LEGAL PROCEEDINGS

NONE

NOTE 8 - INCOME TAXES

At June 30, 2015, the Company had federal and state net operating loss carry-forwards ("NOL")'s of approximately $3,800,000, which are due to expire through fiscal 2034: These NOLs may be used to offset future taxable income through their respective expiration dates and thereby reduce or eliminate our federal and state income taxes otherwise payable. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Ultimate utilization of such NOL's and credits is dependent upon .the Company's ability to generate taxable income in future periods and may be significantly curtailed if a significant change in ownership occurs.

Due to the uncertainty related to future taxable income, the Company provides a 100% valuation allowance for the deferred tax benefit resulting from the NOL's and depreciation and amortization.

NOTE 9 – DUE TO SHAREHOLDER

The Company’s President has been deferring his salary and bonuses periodically to assist the Company’s cash flow. There are no repayment terms or interest accruing on this liability.

NOTE 10 – SUBSEQUENT EVENTS

On August 7, 2015 the Company sold 2,068,965 shares of its $.0005 par value common stock to Advanced Plasma Therapies, Inc. (“APT”) for $300,000.  The shares purchased by APT are restricted securities and have not been registered for public sale.  APT is a privately-held company involved in the development and commercialization of innovative therapeutic medical plasma technologies.  The Company has been providing APT with engineering services for APT's plasma-based medical technologies currently in clinical development and is expected to manufacture APT products for clinical use and for commercial deployment following receipt of applicable regulatory approvals.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our operations and financial condition should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-Q to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item. 1 Description of Business – Risk Factors" and elsewhere in or incorporated by reference into our Annual Report on Form 10-K for the year ended March 31, 2015.      

CRITICAL ACCOUNTING POLICIES

10

REVENUE RECOGNITION

We recognize revenue from engineering services on a project or monthly basis and contract manufacturing revenues are recognized after shipment of completed products. For the sale of our electronic products, revenues are recognized when they are shipped to the purchaser.. Shipping and handling charges and costs are de minimis. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in the sales of our electronic products have been de minimis. We have no other post shipment obligations and sales returns have been de minimis.

Revenues from sales of chemical products are recognized when products are shipped to end users.  Shipments to distributors are recognized as sales where no right of return exists.

USE OF ESTIMATES

Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to reserves, deferred tax assets and valuation allowance, impairment of long-lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above described items, are reasonable.

BUSINESS OVERVIEW

ADM is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. During the three months ended June 30, 2015 and 2014, our operations are conducted through ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary, Sonotron Medical Systems, Inc. ("SMI"). In addition, the Company owns a minority interest in Montvale Technologies, Inc. (formerly known as Ivivi Technologies, Inc.) ("ITI"), which until October 18, 2006 was operated as a subsidiary of the Company. ITI was deconsolidated as of October 18, 2006 upon the consummation of ITI's initial public offering.

We are a technology-based engineering and manufacturing company with diversified lines of products in the following four areas: (1) electronic products for numerous industries, including therapeutic non-invasive electronic medical devices and electronic controllers for spas and hot tubs, (2) environmentally safe chemical products for industrial use, (3) cosmetic and topical dermatological products and (4) antistatic paint and coatings products.

11

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2015 AS COMPARED TO JUNE 30, 2014

For the Three Months Ended June 30, 2015
	Chemical			Electronics			Engineering			Total
Revenue	$	365,944		$	175,229		$	514,755		$	1,055,928
Cost of Sales		53,949			106,350			140,574			300,873
Gross Profit		311,995			68,879			374,181			755,055
Gross Profit Percentage		85	%		39	%		73	%		72	%
Operating Expenses		111,073			53,203			156,231			320,507
Operating Income		200,922			15,676			217,950			434,548
Other income (expenses)		(154	)		(54	)		(112	)		(320	)
Net Income	$	200,768		$	15,622		$	217,838		$	434,228
For the Three Months Ended June 30, 2014
	Chemical			Electronics			Engineering			Total
Revenue	$	297,159		$	242,210		$	84,305		$	623,674
Cost of Sales		90,694			154,064			93,458			338,216
Gross Profit		206,465			88,146			(9,153	)		285,458
Gross Profit Percentage		69	%		36	%		-11	%		46	%
Operating Expenses		118,986			96,982			33,756			249,724
Operating Income (Loss)		87,479			(8,836	)		(42,909	)		35,734
Other income (expenses)		44			37			13			94
Net Income (Loss)	$	87,523		$	(8,799	)	$	(42,896	)	$	35,828
Variance
	Chemical			Electronics			Engineering			Total
Revenue	$	68,785		$	(66,981	)	$	430,450		$	432,254
Cost of Sales		(36,745	)		(47,714	)		47,116			(37,343	)
Gross Profit		105,530			(19,267	)		383,334			469,597
Gross Profit Percentage		16	%		3	%		84	%		26	%
Operating Expenses		(7,913	)		(43,779	)		122,475			70,783
Operating Income (Loss)		113,443			24,512			260,859			398,814
Other income (expenses)		(198	)		(91	)		(125	)		(414	)
Net Income	$	113,245		$	24,421		$	260,734		$	398,400

Revenues were $1,055,928 for the three months ended June 30, 2015 as compared to $623,674 for the three months ended June 30, 2014, an increase of $432,254, or 69%. The increase resulted from an increase in engineering revenue of $430,450 coupled with an increase in sales in our chemical division of $68,785 offset by a decrease in our electronic segment in the amount of $66,981. The increase in engineering services is primarily the result of several projects for one customer.

Gross profit was $755,055, or 71.5%, for the three months ended June 30, 2015 and $285,458, or 45.8% for the three months ended June 30, 2014. The increase in gross profit in the electronics and chemical segments resulted from changes in the mix of products sold. The increase in gross profit in the engineering segment resulted from better utilization of labor due to the increased revenue from new projects from one customer.

We are highly dependent upon certain customers to generate our revenues. During the three month period ended June 30, 2015, one customer accounted for 46% of our revenue. During the three month period ended June 30, 2014, another customer accounted for 18% of our revenue. The complete loss of or significant reduction in business from, or a material adverse change in the financial condition of any of our customers could cause a material and adverse change in our revenues and operating results.    

12

Income from operations for the three months ended June 30, 2015 was $434,548 compared to $35,734 for the three months ended June 30, 2014. Selling, general, and administrative expenses increased by $59,184 or 25%, from $236,037 to $295,221 mainly due to an increase of $40,383 in royalties and commissions and a $17,614 increase in consulting fees.

Interest income decreased $726 to $321 in the three months ended June 30, 2015, from $1,047 in the three months ended June 30, 2014, due to decreased funds invested in a money market account.

The foregoing resulted in net income for the three months ended June 30, 2015 of $434,228, or $0.01 per share, compared to net income for the three months ended June 30, 2014 of $35,828 or $0.00 per share.

LIQUIDITY AND CAPITAL RESOURCES

At June 30, 2015, we had cash and cash equivalents of $370,526 as compared to $216,395 at March 31, 2015. The $154,131 increase was primarily the result of cash provided in operations during the three month period in the amount of $161,392 offset by cash used in financing activities in the amount of $7,000 and cash used in investing activities of $261. Our cash will continue to be used for increased marketing costs, and the related administrative expenses, in order to attempt to increase our revenue.  We expect to have enough cash to fund operations for the next twelve months. Our note payable of $114,966 at June 30, 2015, is secured and collateralized by restricted cash of $232,786. This note bears an interest rate of 2% above the rate of the savings account. The interest rate at June 30, 2015 was 2.15% and is payable upon demand.

Future Sources of Liquidity:

We expect that growth in profitable revenues and continued focus on new customers will enable us to continue to generate cash flows from operating activities during fiscal 2016.

If we do not generate sufficient cash from operations, face unanticipated cash needs or do not otherwise have sufficient cash, we may need to consider the sale of certain intellectual property which does not support the Company’s operations. In addition, we have the ability to reduce certain expenses depending on the level of business operation.

Based on current expectations, we believe that our existing cash of $370,526 as of June 30, 2015 and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

OPERATING ACTIVITIES 

Net cash provided (used) by operating activities was $161,392 for the three months ended June 30, 2015, as compared to net cash used in operating activities of $(9,262) for the three months ended June 30, 2014.  The cash provided during the three months ended June 30, 2015 was primarily due to net income of $434,228 and decreases in operating liabilities of $100,349, and net operating assets of $173,287.   

INVESTING ACTIVITIES

Cash was used in investing activities in the amount of $261 from deposits in the restricted cash in the amount of $261.

FINANCING ACTIVITIES

For the three months ended June 30, 2015 and 2014, net cash used in financing activities were $7,000 and $4,000, respectively which were repayments on a note from a commercial bank to facilitate our acquisition of Action Industries Unlimited, Inc. (AIU).

13

OFF BALANCE SHEET ARRANGEMENTS

We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Concentration of Credit Risk

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and our investment in ITI. We have no control over the market value of our investment in ITI.

We maintain cash and cash equivalents with FDIC insured financial institutions.

Our sales are materially dependent on a small group of customers, as noted in Note 4 of our condensed consolidated financial statements. We monitor our credit risk associated with our receivables on a routine basis. We also maintain credit controls for evaluating and granting customer credit.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

The Company's management, including the Company's principal executive officer and principal financial officer, have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Ru1e 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Based upon their evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective for the purpose of ensuring that the information required to be disclosed in the reports that the Company files or submits under the Exchange Act with the Securities and Exchange Commission (the "SEC") (1) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. During the quarterly period ended June 30, 2015, there were no changes in the Company's internal control over financial reporting which materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting.

The determination that our disclosure controls and procedures were not effective as of June 30, 2015 are a result of:

a. Deficiencies in Internal Control Structure Environment. The Company experienced net losses for the past several years. During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.  

b. Inadequate staffing and supervision within the accounting operations of our company. The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews.  The Company’s plan is to expand its accounting operations as the business of the Company expands.

The Company believes that the financial statements fairly present, in all material respects, the Company’s consolidated balance sheets as of June 30, 2015 and March 31, 2015 and the related statements of operations, stockholders’ equity (deficiency), and cash flows for the three months ended June 30, 2015 and 2014, in conformity with generally accepted accounting principles, notwithstanding the material weaknesses we identified.

14

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

NONE

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended March 31, 2015.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

None

ITEM 5. OTHER INFORMATION

None 

ITEM 6. EXHIBITS.

(a) Exhibit No.

31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**	XBRL Instance
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation
101.DEF**	XBRL Taxonomy Extension Definition
101.LAB**	XBRL Taxonomy Extension Labels
101.PRE**	XBRL Taxonomy Extension Presentation

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

15

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ADM TRONICS UNLIMITED, INC.
(Registrant)
By:	/s/ Andre' DiMino
	Andre' DiMino, Chief Executive
	Officer and Chief Financial Officer

Dated:	Northvale, New Jersey
	August 14, 2015

EX-31.1

EXHIBIT 31.1

CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES - OXLEY ACT OF 2002 AND

SECURITIES AND EXCHANGE COMMISSION RELEASE 34-46427

I, Andre' DiMino, certify that:

1. I have reviewed this report on Form 10-Q of ADM Tronics Unlimited, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am the registrant's only certifying officer and am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 14, 2015	/s/ Andre' DiMino
	Andre' DiMino
	Chief Executive Officer, Chief Financial Officer

A signed original of this written statement required by Section 302 has been provided to ADM Tronics Unlimited, Inc. and will be retained by ADM Tronics Unlimited, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ADM Tronics Unlimited, Inc. (the "Company") on Form 10-Q for the three months ended June 30, 2015, (the "Report"), filed with the Securities and Exchange Commission, Andre' DiMino, Chief Executive Officer and Chief Financial Officer, of the Company hereby certifies pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the result of operations of the Company for the periods presented. 

Date: August 14, 2015	/s/ Andre' DiMino
	Chief Executive Officer and
	Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ADM Tronics Unlimited, Inc. and will be retained by ADM Tronics Unlimited, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Note 6 - Options Outstanding (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				5,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		5,000,000	5,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			$ 55,997
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate			4.90%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate			414.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			1 year 182 days
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate			0.00%

XML

Note 4 - Concentrations

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

NOTE 4 – CONCENTRATIONS

During the three month period ended June 30, 2015, one customer accounted for 46% of our revenue and approximately 48% of our accounts receivable as of June 30, 2015.

During the three month period ended June 30, 2014, one customer accounted for 18% of our revenue. As of June 30, 2014, three customers represented approximately 52% of our accounts receivable.

The Company’s customer base is comprised of domestic and foreign entities with diverse demographics. Revenues from foreign customers represented $101,313 of net revenue or 9.6% for the three months ended June 30, 2015 and $40,095 of net revenue or 6.4% for the three months ended June 30, 2014.

As of June 30, 2015 and 2014, accounts receivable included $50,637 and $4,300, respectively, from foreign customers.

XML

Note 8 - Income Taxes (Details Textual) - Jun. 30, 2015 - USD ($)	Total
Operating Loss Carryforwards	$ 3,800,000
Deferred Tax Assets, Valuation Allowance, Percentage	100.00%

XML

Note 7 - Commitments and Contingencies - Future Minimum Lease Payments (Details)	Jun. 30, 2015 USD ($)
2016	$ 104,625
2017	104,625
2018	104,625
	$ 313,875

XML

Note 9 - Due to Shareholder (Details Textual)	Jun. 30, 2015 USD ($)
Deferred Compensation Liability, Interest Accrued	$ 0

XML

Note 10 - Subsequent Events (Details Textual) - USD ($)	Aug. 07, 2015	Jun. 30, 2015	Mar. 31, 2015
Restricted Stock [Member] | Private Placement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	2,068,965
Common Stock, Par or Stated Value Per Share	$ 0.0005
Proceeds from Issuance of Common Stock	$ 300,000
Common Stock, Par or Stated Value Per Share		$ 0.0005	$ 0.0005

XML

Note 3 - Inventory

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Inventory Disclosure [Text Block]

NOTE 3 - INVENTORIES

Inventories at June 30, 2015 consisted of the following:

	Current		Long Term		Total
Raw materials	$	139,584	$	84,285	$	223,869
Finished Goods		27,208		619		27,827
	$	166,792	$	84,904	$	251,696

Inventories at March 31, 2015 consisted of the following:

	Current		Long Term		Total
Raw materials	$	95,702	$	87,638	$	183,340
Finished Goods		42,002		619		42,621
	$	137,704	$	88,257	$	225,961

The Company values its inventories on the first in, first out ("FIFO") method at the lower of cost or market.

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Current assets:
Cash and cash equivalents	$ 370,526	$ 216,395
Accounts receivable, net of allowance for doubtful accounts of $25,000 for each period	750,803	616,070
Inventories	166,792	137,704
Prepaid expenses and other current assets	29,414	16,595
Restricted cash	232,786	232,525
Total current assets	1,550,321	1,219,289
Property and equipment, net of accumulated depreciation of $74,522 and $74,070, respectively	2,794	3,246
Inventories - long-term portion	84,904	88,257
Intangible assets, net of accumulated amortization of $154,015 and $153,667, respectively	14,133	14,481
Other assets	16,144	16,144
Total other assets	117,975	122,128
Total assets	1,668,296	1,341,417
Current liabilities:
Note payable - bank	114,966	121,966
Accounts payable	173,216	329,291
Accrued expenses and other current liabilities	266,840	221,106
Customer deposits	99,102	99,102
Due to shareholder	233,841	223,849
Total current liabilities	887,965	995,314
Total liabilities	$ 887,965	$ 995,314
Stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.0005 par value; 150,000,000 authorized, 64,939,537 shares issued and outstanding at March 31, 2015 and 2014, respectively	$ 32,470	$ 32,470
Additional paid-in capital	32,298,094	32,298,094
Accumulated deficit	(31,550,233)	(31,984,461)
Total stockholders' equity	780,331	346,103
Total liabilities and stockholders' equity	$ 1,668,296	$ 1,341,417

XML

Note 1 - Nature of Business

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

NOTE 1 - NATURE OF BUSINESS

ADM Tronics Unlimited, Inc. ("we", "us", the “Company" or "ADM"), was incorporated under the laws of the state of Delaware on November 24, 1969. We are an engineering and manufacturing concern whose principal lines of business are engineering and manufacturing of electronics, primarily medical electronic devices, and the development, production and sale of chemical products.

The accompanying condensed consolidated financial statements as of June 30, 2015 (unaudited) and March 31, 2015 and for the three month periods ended June 30, 2015 and 2014 (unaudited) have been prepared by ADM pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the condensed financial position and operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the information included under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with the audited financial statements and explanatory notes for the year ended March 31, 2015 as disclosed in our annual report on Form 10-K for that year . The operating results and cash flows for three months ended June 30, 2015 (unaudited) are not necessarily indicative of the results to be expected for the pending full year ending March 31, 2016.

XML

Note 3 - Inventory - Summary of Inventory (Details) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Current [Member]
Raw materials	$ 139,584	$ 95,702
Finished Goods	27,208	42,002
	166,792	137,704
Long Term [Member
Raw materials	84,285	87,638
Finished Goods	619	619
	84,904	88,257
Raw materials	223,869	183,340
Finished Goods	27,827	42,621
	$ 251,696	$ 225,961

XML

Note 5 - Segment Information - Summary of Segment Information (Details) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015
Chemical [Member]
Revenues	$ 365,944	$ 297,159
Segment operating income (loss)	200,900	87,479
Total assets	578,168		$ 509,738
Electronics [Member]
Revenues	175,229	242,210
Segment operating income (loss)	15,668	(8,836)
Total assets	276,851		389,011
Engineering [Member]
Revenues	514,755	84,305
Segment operating income (loss)	217,980	(42,909)
Total assets	813,277		442,868
Revenues	1,055,928	623,674
Segment operating income (loss)	434,548	$ 35,734
Total assets	$ 1,668,296		$ 1,341,417

XML

Note 2 - Significant Accounting Policies

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Significant Accounting Policies [Text Block]

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its subsidiary Sonotron. All significant intercompany balances and transactions have been eliminated in consolidation.

USE OF ESTIMATES

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our medical devices, reserves, deferred tax assets, valuation allowance, impairment of long lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others, option and warrant expenses related to compensation to employees and directors, consultants and investment banks, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates. 

REVENUE RECOGNITION

CHEMICAL PRODUCTS:

 Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

ELECTRONICS: 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. We have no other post shipment obligations. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for each of the fiscal years ended March 31, 2015 and 2014. For contract manufacturing, revenues are recognized after shipment of the completed products. 

ENGINEERING SERVICES: 

We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services as the services are provided.

 NET INCOME PER SHARE

Basic net income per share is calculated based on the weighted average number of common shares outstanding during the periods. Diluted net income per share is computed similar to basic income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive.

Per share basic and diluted net income amounted to $0.01 and $0.00 for the three months ended June 30, 2015 and 2014, respectively. There were 600,000 common stock equivalents at June 30, 2015 and 2014, respectively.

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current period presentation.

RECENT ACCOUNTING PRONOUNCEMENTS

Management does not believe that any recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2015	Mar. 31, 2015
Allowance for doubtful accounts	$ 25,000	$ 25,000
Accumulated depreciation	74,522	74,070
Accumulated amortization	$ 154,015	$ 153,667
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	64,939,537	64,939,537
Common stock, shares outstanding (in shares)	64,939,537	64,939,537

XML

Note 3 - Inventory (Tables)

3 Months Ended

Jun. 30, 2015

Notes Tables

Schedule Of Inventory [Table Text Block]

	Current		Long Term		Total
Raw materials	$	139,584	$	84,285	$	223,869
Finished Goods		27,208		619		27,827
	$	166,792	$	84,904	$	251,696

	Current		Long Term		Total
Raw materials	$	95,702	$	87,638	$	183,340
Finished Goods		42,002		619		42,621
	$	137,704	$	88,257	$	225,961

XML

Document And Entity Information - shares	3 Months Ended
	Jun. 30, 2015	Aug. 14, 2015
Entity Registrant Name	ADM TRONICS UNLIMITED, INC.
Entity Central Index Key	0000849401
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		67,008,502
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Note 5 - Segment Information (Tables)

3 Months Ended

Jun. 30, 2015

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Chemical		Electronics			Engineering			Total
Three months ended June 30, 2015
Revenue from external customers	$	365,944	$	175,229		$	514,755		$	1,055,928
Segment operating income (loss)	$	200,900	$	15,668		$	217,980		$	434,548
Year ended June 30, 2014
Revenue from external customers	$	297,159	$	242,210		$	84,305		$	623,674
Segment operating income (loss)	$	87,479	$	(8,836	)	$	(42,909	)	$	35,734
Total assets at June 30, 2015	$	578,168	$	276,851		$	813,277		$	1,668,296
Total assets at March 31, 2015	$	509,738	$	389,011		$	442,868		$	1,341,417

XML

Condensed Consolidated Statements of Operations (Unaudtied) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Net revenues	$ 1,055,928	$ 623,674
Cost of sales	300,873	338,216
Gross Profit	755,055	285,458
Operating expenses:
Research and development	24,689	12,045
Selling, general, and administrative	295,221	236,037
Depreciation and amortization	597	1,642
Total operating expenses	320,507	249,724
Income from operations	434,548	35,734
Other income (expense):
Interest income	321	1,047
Interest expense	(641)	(953)
Total other income (expense)	(320)	94
Net income	$ 434,228	$ 35,828
Basic and diluted net income per common share: (in dollars per share)	$ 0.01	$ 0
Weighted average shares of common stock outstanding - basic (in shares)	64,939,537	64,939,537
Weighted average shares of common stock outstanding - diluted (in shares)	65,539,537	65,539,537

XML

Note 7 - Commitments and Contingencies

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

NOTE 

7

 - COMMITMENTS AND CONTINGENCIES

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on June 30, 2019. The Company’s future minimum lease commitment at June 30, 2015 is as follows:

For the twelve month period ending June 30,	Amount
2016	$	104,625
2017		104,625
2018		104,625
	$	313,875

Rent and real estate tax expense for all facilities for the three months ended June 30, 2015 and 2014 was approximately $31,000 respectively, for each period.

MASTER SERVICES AGREEMENT 

On February 12, 2010, ADM agreed to provide certain services to Ivivi Health Sciences, LLC (IHS) pursuant to a Master Services Agreement, as described below:

● We provided IHS with engineering services, including quality control and quality assurance services along with regulatory compliance services, warehouse fulfillment services and network administrative services including hardware and software services;

● Effective October 1, 2013 the monthly amount to be paid by IHS for these services was $3,000 plus additional amounts for individual projects requested from time to time by IHS. Pursuant to this agreement, revenues from engineering services to IHS were $9,000 for the three months ended June 30, 2015 and 2014 respectively.

LEGAL PROCEEDINGS

NONE

XML

Note 6 - Options Outstanding

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

N

OTE

6

- OPTIONS OUTSTANDING

During 2013, ADM granted an aggregate of 5,600,000 stock options to employees and consultants expiring at various dates through fiscal 2015. During 2014, 5,000,000 of the outstanding stock options were exercised. The options had various exercise prices and were fully vested at the date of grant. The options were valued at $55,997 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 4.9%, volatility of 414%, estimated useful life of 1.5 years and dividend rate of 0%. The following table summarizes information on all common share purchase options issued by us as of June 30, 2015 and 2014.

	2015				2014
	# of Shares		Weighted Average Exercise Price		# of Shares			Weighted Average Exercise Price
Outstanding, beginning of year		600,000	$	0.01		5,600,000		$	0.01
Issued		-	$	-		-		$	-
Exercised		-	$	-		(5,000,000	)	$	0.01
Expired		-	$	-		-		$	-
Outstanding, end of year		600,000	$	0.01		600,000		$	0.01
Exercisable, end of year		600,000	$	0.01		600,000		$	0.01

XML

Note 4 - Concentrations (Details Textual)	3 Months Ended
	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)	Mar. 31, 2015 USD ($)
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Foreign Customers [Member]
Concentration Risk, Percentage	9.60%	6.40%
Revenues	$ 101,313	$ 40,095
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Number of Customers	1	1
Concentration Risk, Percentage	46.00%	18.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Foreign Customers [Member]
Accounts Receivable, Net, Current	$ 50,637	$ 4,300
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Number of Customers		3
Concentration Risk, Percentage	48.00%	52.00%
Revenues	$ 1,055,928	$ 623,674
Accounts Receivable, Net, Current	$ 750,803		$ 616,070

XML

Note 6 - Options Outstanding (Tables)

3 Months Ended

Jun. 30, 2015

Notes Tables

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	2015				2014
	# of Shares		Weighted Average Exercise Price		# of Shares			Weighted Average Exercise Price
Outstanding, beginning of year		600,000	$	0.01		5,600,000		$	0.01
Issued		-	$	-		-		$	-
Exercised		-	$	-		(5,000,000	)	$	0.01
Expired		-	$	-		-		$	-
Outstanding, end of year		600,000	$	0.01		600,000		$	0.01
Exercisable, end of year		600,000	$	0.01		600,000		$	0.01

XML

Note 10 - Subsequent Events

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Subsequent Events [Text Block]

NOTE 1

0

 – SUBSEQUENT EVENTS

On August 7, 2015 the Company sold 2,068,965 shares of its $.0005 par value common stock to Advanced Plasma Therapies, Inc. (“APT”) for $300,000.  The shares purchased by APT are restricted securities and have not been registered for public sale.  APT is a privately-held company involved in the development and commercialization of innovative therapeutic medical plasma technologies.  The Company has been providing APT with engineering services for APT's plasma-based medical technologies currently in clinical development and is expected to manufacture APT products for clinical use and for commercial deployment following receipt of applicable regulatory approvals.

XML

Note 8 - Income Taxes

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Income Tax Disclosure [Text Block]

NOTE

8

- INCOME TAXES

At June 30, 2015, the Company had federal and state net operating loss carry-forwards ("NOL")'s of approximately $3,800,000, which are due to expire through fiscal 2034

: 

These NOLs may be used to offset future taxable income through their respective expiration dates and thereby reduce or eliminate our federal and state income taxes otherwise payable. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Ultimate utilization of such NOL's and credits is dependent upon .the Company's ability to generate taxable income in future periods and may be significantly curtailed if a significant change inownership occurs.

Due to the uncertainty related to future taxable income, the Company provides a 100% valuation allowance for the deferred tax benefit resulting from the NOL's and depreciation and amortization.

XML

Note 9 - Due to Shareholder

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Compensation Related Costs, General [Text Block]

NOTE

9

 – DUE TO SHAREHOLDER

The Company’s President has been deferring his salary and bonuses periodically to assist the Company’s cash flow. There are no repayment terms or interest accruing on this liability.

XML

Significant Accounting Policies (Policies)

3 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its subsidiary Sonotron. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates, Policy [Policy Text Block]

USE OF ESTIMATES

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our medical devices, reserves, deferred tax assets, valuation allowance, impairment of long lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others, option and warrant expenses related to compensation to employees and directors, consultants and investment banks, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates. 

Revenue Recognition, Policy [Policy Text Block]

REVENUE RECOGNITION

CHEMICAL PRODUCTS:

 Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

ELECTRONICS: 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. We have no other post shipment obligations. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for each of the fiscal years ended March 31, 2015 and 2014. For contract manufacturing, revenues are recognized after shipment of the completed products. 

ENGINEERING SERVICES: 

We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services as the services are provided.

Earnings Per Share, Policy [Policy Text Block]

 NET INCOME PER SHARE

Basic net income per share is calculated based on the weighted average number of common shares outstanding during the periods. Diluted net income per share is computed similar to basic income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive.

Per share basic and diluted net income amounted to $0.01 and $0.00 for the three months ended June 30, 2015 and 2014, respectively. There were 600,000 common stock equivalents at June 30, 2015 and 2014, respectively.

Reclassification, Policy [Policy Text Block]

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current period presentation.

New Accounting Pronouncements, Policy [Policy Text Block]

RECENT ACCOUNTING PRONOUNCEMENTS

Management does not believe that any recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

XML

Note 2 - Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015	Mar. 31, 2014
Maximum [Member]
Product Warranty Expense			$ 2,000	$ 2,000
Electronic Products [Member]
Warranty Term	90 days
Electronic Controllers for Spas and Hot Tubs [Member]
Warranty Term	5 years
Product Warranty Accrual, Current	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	600,000	600,000
Earnings Per Share, Basic and Diluted	$ 0.01	$ 0

XML

Note 6 - Options Outstanding - Summary of Stock Option Activity (Details) - $ / shares	3 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2014
Outstanding, beginning of year (in shares)	600,000	5,600,000
Outstanding, beginning of year (in dollars per share)	$ 0.01	$ 0.01
Issued (in shares)
Issued (in dollars per share)
Exercised (in shares)		(5,000,000)	(5,000,000)
Exercised (in dollars per share)		$ 0.01
Expired (in shares)
Expired (in dollars per share)
Outstanding, end of year (in shares)	600,000	600,000	5,600,000
Outstanding, end of year (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Exercisable, end of year (in shares)	600,000	600,000
Exercisable, end of year (in dollars per share)	$ 0.01	$ 0.01

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net income	$ 434,228	$ 35,828
Adjustments to reconcile net income to net cash provided (used) in operating activities:
Depreciation and amortization	$ 800	1,642
Interest receivable		(1,047)
Increase (decrease) in cash flows as a result of changes in net assets and liabilities balances:
Accounts receivable	$ (134,733)	(111,136)
Inventory	(25,736)	(82,996)
Prepaid expenses and other current assets	$ (12,818)	(23,838)
Other assets		(1,000)
Accounts payable	$ (156,075)	47,442
Accrued expenses and other current liabilities	45,734	$ 125,843
Due to shareholder	9,992
Total adjustments	(272,836)	$ (45,090)
Net cash provided (used) in operating activities	161,392	$ (9,262)
Cash flows from investing activities:
Restricted cash	(261)
Net cash used in investing activities	(261)
Cash flows used in financing activities:
Repayments on note payable - Bank	(7,000)	$ (4,000)
Net cash used in financing activities	(7,000)	(4,000)
Net increase (decrease) in cash and cash equivalents	154,131	(13,262)
Cash and cash equivalents - beginning of year	216,395	83,156
Cash and cash equivalents - end of year	370,526	69,894
Cash paid for:
Interest	$ 641	$ 953

XML

Note 5 - Segment Information

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

NOTE

5

- SEGMENT INFORMATION

Information about segments is as follows:

	Chemical		Electronics			Engineering			Total
Three months ended June 30, 2015
Revenue from external customers	$	365,944	$	175,229		$	514,755		$	1,055,928
Segment operating income (loss)	$	200,900	$	15,668		$	217,980		$	434,548
Year ended June 30, 2014
Revenue from external customers	$	297,159	$	242,210		$	84,305		$	623,674
Segment operating income (loss)	$	87,479	$	(8,836	)	$	(42,909	)	$	35,734
Total assets at June 30, 2015	$	578,168	$	276,851		$	813,277		$	1,668,296
Total assets at March 31, 2015	$	509,738	$	389,011		$	442,868		$	1,341,417

XML

Note 7 - Commitments and Contingencies (Details Textual) - USD ($)		3 Months Ended
	Oct. 01, 2013	Jun. 30, 2015	Jun. 30, 2014
IHS [Member] | Engineering Services [Member]
Sales Revenue, Services, Net	$ 3,000	$ 9,000	$ 9,000
Operating Leases, Rent Expense		$ 31,000	$ 31,000

XML

Note 7 - Commitments and Contingencies (Tables)

3 Months Ended

Jun. 30, 2015

Notes Tables

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

For the twelve month period ending June 30,	Amount
2016	$	104,625
2017		104,625
2018		104,625
	$	313,875